MW150 Stress Kinase Inhibitor in Mild to Moderate Alzheimer's Disease
- First Posted Date
- 2022-01-18
- Last Posted Date
- 2022-03-29
- Lead Sponsor
- Neurokine Therapeutics
- Target Recruit Count
- 24
- Registration Number
- NCT05194163
- Locations
- 🇺🇸
Columbia University Irving Medical Center, New York, New York, United States
© Copyright 2025. All Rights Reserved by MedPath